{
    "2020-12-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Here's the Hot Target for Multiple Myeloma Drugs",
                "features": {
                    "keywords": [
                        "Hot Target",
                        "Multiple Myeloma",
                        "Drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Next Big Catalysts to Watch in the COVID Vaccine Race",
                "features": {
                    "keywords": [
                        "Next Big Catalysts",
                        "COVID",
                        "Vaccine",
                        "Race"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Better Coronavirus Stock: Johnson & Johnson vs. Pfizer",
                "features": {
                    "keywords": [
                        "Coronavirus Stock",
                        "Johnson & Johnson",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}